Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6-year retrospective study.
Henry SchmidtArighno DasHannah NamAmy YangMichael G IsonPublished in: Influenza and other respiratory viruses (2019)
Respiratory syncytial virus in hospitalized adults is associated with significant morbidity and mortality with 26.9% requiring ICU level care. Antibiotics are commonly prescribed to patients with documented RSV, and antibiotics are frequently continued after diagnosis. Novel antiviral therapies are needed for RSV to improve outcomes and potentially improve antibiotic stewardship in patients without a bacterial infection.
Keyphrases
- respiratory syncytial virus
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- intensive care unit
- prognostic factors
- peritoneal dialysis
- metabolic syndrome
- risk factors
- quality improvement
- mechanical ventilation
- patient reported outcomes
- adipose tissue
- extracorporeal membrane oxygenation